Heron Therapeutics | HRTX - Ebit

金融业

USD

USD 246.22M

现金及等价物

USD 26.12M

USD 11.12M

USD 228.98M

USD 90.52M

USD 149.65M

股息收益率

0

USD 38K

USD -3.88M

126

EPS每股收益

USD -0.02

股本和储备

USD 9.14M

USD 29.47M

债务利息支出

USD 600K

USD 433K

USD 140.64M

USD 130.9M

USD -2.95M

USD 40.55M

USD 38K

普通股股本

USD 188.31M

USD -2.95M

USD 40.59M

销售和管理费用

USD 23.74M

USD 54.57M

贸易债权人

USD 8.97M

应收帐款人

USD 89.59M

	Ebit	更改		日
ALKERMES	USD -48.28M		37.33M	2026-03
Alnylam Pharmaceuticals	USD 137.59M		108.19M	2026-03
Amarin	USD -2.26M		564K	2025-12
ANI Pharmaceuticals	USD 38.71M		9.58M	2026-03
Anika Therapeutics	USD 646K		3.88M	2025-12
Arrowhead Research	USD -141.26M		182.07M	2026-03
Eisai	JPY -10.31B		30.35B	2026-03
Esperion Therapeutics	USD 85.23M		95.19M	2025-12
GlaxoSmithKline	GBP 2.29B		856M	2026-03
Heron Therapeutics	USD 38K		3.83M	2025-12
Insmed	USD -200.28M		49.43M	2026-03
Ligand Pharmaceuticals	USD 60.33M		1.76M	2026-03
Merck	USD -1.88B		8.12B	2026-03
Nektar Therapeutics	USD -19.09M		15.26M	2025-12
Neurocrine Biosciences	USD 214.6M		13.3M	2026-03
Omeros	USD -48.15M		7.25M	2023-09
Pacira	USD 4.62M		1.43M	2026-03
Regeneron Pharmaceuticals	USD 744.8M		153.8M	2026-03
Roche Holding	CHF 9.56B		2.1B	2025-12
Surmodics	USD 58K		380K	2025-06
Ultragenyx Pharmaceutical	USD -216M		102M	2026-03
Veracyte	USD 19.08M		5.55M	2026-03
Vertex Pharmaceuticals	USD 1.14B		124.5M	2026-03